drugset / Trial / NCT00083577
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research is to study how helpful thalidomide is in controlling the myeloma disease and to study any side effect resulting from thalidomide.
Timeline
- Start
- 1998-02
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | Oral |